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ABSTRACT
Background and Objectives: Enterococci are important nosocomial agents and strains resistant to penicillin and
other antibiotics occur frequently. Enterococci are intrinsically resistant to cephalosporins and offer low level
resistance to aminoglycosides. In penicillin sensitive strains, synergism occurs with combination treatment with
penicillin and aminoglycoside. Serious infections caused by them are treated with penicillin and aminoglycoside
combination. But the synergistic effect is lost, when the strain develops high level aminoglycoside resistance. The
choice of drug for infections due to such strains is vancomycin. The present study was carried out to isolate and
speciateEnterococci from various clinical samples, to know the susceptibility pattern of the isolates, to determine
the High  Level  Aminoglycoside  Resistance  (HLAR)  among Enterococcal isolates.Methods:  A  total  of One
hundred Enterococcal species isolated from various clinical samples were identified by various biochemical
reactions.Antimicrobial  susceptibilitytesting and HLAR  were determined  by  Kirby- Bauer  disc  diffusion
method.Results:  Out  of  100 Enterococcal isolates,  59  were E.faecalis,  38  were E.  faecium,3  were  other
Enterococcal species. Among these 53 isolates showed High Level Aminoglycoside Resistance. Conclusion:
Present study shows the presence of drug resistance to most of commonly used antibiotics and HLAR is also more
in E.faecium compared to E.fecalis.
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INTRODUCTION
The Genus Enterococcus consists of Gram positive,
aerobic and facultative anaerobic organisms that are
oval in shape and may appear on smears in pairs, as
singles or short chains. E. fecalis is the most common
isolate,  being  associated  with  80-90  %  of  human
Enterococcal infections
.1
Enterococcus species cause  urinary  tract  infections,
bacteremia,  endocarditis,  intraabdominal  and  pelvic
infections,  wound  and soft  tissue  infections.
2 High
level  aminoglycoside  resistance, glycopeptides
resistance and beta lactamase production in
Enterococci causing  treatment  difficulties  in
hospitals.
3
Drug resistant Enterococci are due to indiscriminate
use  of  antibiotics,  diabetes  mellitus,  prolonged
hospital  stay  and  immunocompromised
states.
3Enterococci are  intrinsically  resistant  to
cephalosporins  and  also  low  level  aminoglycoside
resistance. Infections due to Enterococci are treated
with penicillin and aminoglycoside.This synergism is
lost if the strain develops high level aminoglycoside
resistance.
4The present study was done to know the
antimicrobial  susceptibility  including  HLAR
detection in various Enterococci species.
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MATERIALS AND METHODS
The  present  study  was  done  in  the  department  of
Microbiology,  Dr.B.R.Ambedkar  Medical
College,Bangalore, over a period of one year and four
months from September 2012 to December 2013.A
total of 100 Enterococci isolates from various clinical
samples (urine, pus, wound swabs, blood and other
body  fluids) from  both  OPD  and  IPD
(Medicine,Surgery,OBG,Paediatrics  Departments)
were included  in  the  study.  Urine  samples  were
inoculated on Cysteine Lactose Electrolyte Deficient
(CLED) medium.
5 Blood samples were processed in
blood culture bottles containing glucose broth and the
remaining  clinical specimens  were processed  on
blood agar and MacConkey’s agar. All plates were
incubated  aerobically  at  37
oC  for  24-48  h  and
examined  for microbial growth. Enterococci were
identified using standard methods.
1 Based on colony
morphology,  Gram  staining,  catalase  reaction,  bile
esculin  test,  growth  in  6.5%  NaCl  and  sugar
fermentation reactions.
1 Isolates were identified by
standard biochemical tests.
1
Antimicrobial sensitivity testing was done on Muller-
Hinton agar by standard disc diffusion methods as per
Clinical  Laboratory  StandardsInstitute  (CLSI)
guidelines.
6
The  antibiotics  tested  were  as  follows:  Penicillin
(10U), Ampicillin  (10ug),Ciprofloxacin (5ug),
Vancomycin  (30ug),Linezolid  (30ug)and
Tetracycline (30ug).
Quality control :E. faecalis ATCC 29212 was used .
All the clinical Isolates were detected for HLAR as
per CLSI guidelines using high content Gentamicin
(120ug) and high content Streptomycin (300ug) discs.
A zone of inhibition <6mm indicated as resistant, 7-9
mm inconclusive, >10mm as sensitive.
6
RESULTS
Of  the  100  samples,  61  were  males  and  39  were
females. Various Enterococcal species isolated were
E.  faecalis (59), E.faecium (38), E.dispar (02)  and
E.durans (01).
E.faecium isolates  were  more  resistant  to  various
antibiotics-Penicillin(52%),  Ampicillin  (58%),
Ciprofloxacin(82%),  Vancomycin
(05%),Linezolid(03%)  and
Tetracycline(62%).E.faecaliswere  resistant  to
Penicillin  (48%),  Ampicillin (40%),  Ciprofloxacin
(70%),  Vancomycin  (02%),  Linezolid  (02%)  and
Tetracycline (55%).
HLAR  was  detected  in  53%  of  isolates.  HLAR
among E.  faecium isolates  (58%)  were higher
thanE.fecalis (48%). High  level  resistance  to
gentamicin and streptomycin among E. fecalis strains
were  56%  and  40%  respectively.  High  level
resistance  to gentamicin  and  streptomycin  among
E.faecium strains  were  68%  and  48%  respectively.
Combined  resistance  to  both  aminoglycosides  was
slightly  higher  in E.  faecium (58%) isolates  as
compared with E. fecalis (48%).
Table 1:  Details of type of specimens from which isolates were obtained
Sr.
no.
Specimen(n=100) E. faecalis(%) E.faecium(%) E.dispar
(%)
E.durans
(%)
1 Urine 38 22 01 01
2 Pus 10 08 01 -
3 Sputum 06 05 - -
4 Blood 05 03 - -
5 Total 59 38 02 01
Table 2: Resistance pattern ofE.faecium
Sr.
no.
Specimen(n=38) Penicillin
(%)
Ampicillin
(%)
Ciprofloxacin
(%)
Vancomycin
(%)
Linezolid
(%)
Tetracycline
(%)
1 Urine 34 40 65 03 01 48
2 Pus 09 08 10 02 01 08
3 Sputum 05 05 04 - - 03
4 Blood 04 05 03 - 01 03
5 Total 52 58 82 05 03 62528
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Table 3: Resistance pattern ofE.faecalis
Sr.
no.
Specimen(n=59) Penicillin
(%)
Ampicillin
(%)
Ciprofloxacin
(%)
Vancomycin
(%)
Linezolid
(%)
Tetracycline
(%)
1 Urine 32 33 54 01 01 44
2 Pus 08 04 11 - 01 05
3 Sputum 04 02 02 01 - 03
4 Blood 04 01 03 - - 03
5 Total 48 40 70 02 02 55
Table 4: HLAR pattern
Sr. no. Specimen (n=100) E.faecium(%) E.fecalis(%)
1 Urine 45 38
2 Pus 08 06
3 Sputum 02 02
4 Blood 03 02
5 Total 58 48
DISCUSSION
Enterococci are the second most common cause of
nosocomial urinary tract and wound infections and
third most common cause of nosocomial bacteremias.
Because  of  their  resistance  to  penicillin  and
cephalosporins of several generations, the acquisition
of high level aminoglycoside resistance and now the
emergency  of  vancomycin  resistance,  these
organisms are involved in serious super infections in
patients  receiving  broad  spectrum  antimicrobial
therapy.
1So it is essential to know the susceptibility
pattern of these organisms.
We isolated E. faecalis more than that of E. faecium.
The same results were obtained by Mendiratta DK et
al
.7,Bhat  KG  et  al
8and  Gupta et  al
.9High  level
aminoglycoside  resistance Enterococci were  first
reported  in  France  in  1979  and  then  have  been
isolated from all the continents
.10Our study showedE.
faecium isolates were more drug resistant compared
to E.  faecalis.  This  is  comparable  to  the  results
reported by AnjanaTelkaretal.
11
In  our  study  majority  of  the Enterococcal isolates
were  resistant  to  tetracycline,  and ciprofloxacin,
which  is  comparable  to  the study  conducted  by
AnjanaTelkar et al
.11
Overall,  resistance  to  penicillin, ampicillin
andciprofloxacin among strains of E. faecium is high.
Linezolid  showed  a  good  sensitivity  towards
Enterococci species,  and  this  can  be  used  as  an
alternative for the vancomycin resistant Enterococci.
In  our  study E.  faecium isolates  were  multi drug
resistant  as  compared  to E.fecalis,  which  is
comparable to the results reported by  Mendiratta et
al.
7 and  Bhat  KG  et  al.
8Vancomycin  resistance
detected in 7% of the isolates. Similar results were
reported by Bhat KG et al.
8.
In  our  study  HLGR  is  more in E. faecium isolates
(68%)  compared  to E.  faecalis (56%)  strains. Also
HLSR is more inE.faecium (48%) than in E.faecalis
(40%).  The  same  results  were  reported  by
Mendirattaetal
.7 and Gupta  V  et  al.
9So  high
percentages of  HLAR  could  nullify  efficacy  of
combination  therapy  of  Beta lactamase,
aminoglycosides  recommended  for  the  treatment  of
serious Enterococcal infections.Karmarkaret al
12 also
reported greater resistance to vancomycin among E.
faecium.
The  higher  antimicrobial  resistance  rates  in  the
present study may be ascribed to the source of the
isolates being from a tertiary care set up and a wider
usage of broad spectrum antibiotics.
CONCLUSION
In our study multidrug resistant and HLAR is more in
Enterococcal isolates.It is essential to screen for the
multidrug resistant and HLAR in clinical samples.So
proper antibiotic policy and hospital infection control
measures can be initiated to prevent the emergence of
multidrug resistant strains.529
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